Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Young colorectal cancer patients commonly diagnosed at advanced stages, survey finds

Patients diagnosed with colorectal cancer prior to turning 50 were often misdiagnosed, which may result in a diagnosis at more advanced stages of the disease, according to the American Association for Cancer Research (AACR).  

March 1, 2019

DBT detects smaller cancers with better long-term prognoses

DBT also identified more cancers and lowered recall rates in patients of all ages and breast density types.

February 28, 2019
""

Cardiac MRI-derived T2 mapping may help heart failure patients

Researchers used T2 mapping taken from weekly cardiac MRIs to help identify cardiotoxicity at an early stage, according to results of a pig study published Feb. 18 in the Journal of the American College of Cardiology. The findings could help cancer patients at risk of chemo-induced heart failure.

February 22, 2019

T2 mapping may uncover cardiotoxic marker early enough to prevent heart failure

T2 mapping derived from weekly cardiac MRIs helped researchers identify cardiotoxicity at an early and reversible stage, a finding which may have implications for cancer patients at risk of chemotherapy-induced heart failure.

February 21, 2019

More men with low-risk prostate cancer are choosing active surveillance

Traditionally, men with low-risk prostate cancer had undergone radical prostatectomy or radiation, but many are now opting for a more conservative active surveillance approach, according to a Feb. 11 analysis published in JAMA.

February 12, 2019

Stereotactic radiation can extend survival for late-stage cancer patients

“In this study, for patients with stage-IV disease, we have a treatment paradigm that can result in long-term survival while maintaining overall quality of life,” said senior author of the study, Dwight E. Heron, MD.

February 1, 2019

Some chemo drugs might be more heart-safe than others

Current conversion ratios may be underestimating the long-term cardiotoxicity of common chemotherapy agents like mitoxantrone and overestimating the cardiovascular risk of anthracyclines like daunorubicin, researchers reported in JAMA Oncology Jan. 31.

February 1, 2019

Is now the time to rename low-risk cancers?

A pair of specialists recently took on the topic of the word "cancer" in a Jan. 23 viewpoint published in The BMJ, arguing that changing the terminology could ease patient anxiety or create more fear.

January 28, 2019